Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Antimicrobial Resistance

    New Method to Improve Antibiotic Production

    By Global Biodefense StaffJuly 15, 2013
    Share
    Facebook LinkedIn Reddit Email

    PlanomonosporaAn antibiotic has been found to stimulate its own production, a discovery which could make it easier to scale up antibiotic production for commercialization.

    Scientists Dr. Emma Sherwood and Professor Mervyn Bibb from the John Innes Centre (JIC) were able to use their discovery of how the antibiotic is naturally produced to markedly increase the level of production. Their findings have been published in PNAS.

    “We have shown for the first time that an antibiotic with clinical potential can act as signaling molecule to trigger its own synthesis,” said Professor Bibb.

    The antibiotic called planosporicin is produced by a soil bacterium called Planomonospora alba. When nutrients become limited, a small amount of the antibiotic is produced. The antibiotic is then able to trigger a mechanism that coordinates its own production throughout the bacterial population resulting in high levels.

    “A frequent stumbling block in developing a natural product for commercialization is being able to provide enough material for clinical trials,” said Professor Bibb.

    “Our work shows with the right understanding it is possible to increase productivity very dramatically in a targeted and knowledge-based manner.”

    With knowledge of this signaling mechanism in hand, the scientists were able to increase production by over-expressing two positively acting regulatory genes and deleting one that acts negatively. Planosporicin is similar to the antibiotic NAI-107 that is about to enter clinical trials for Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) infections. The knowledge gained from this study is being used to increase NAI-107 production.

    Commercial manufacturers of antibiotics may be able to use the results to reduce production times and therefore reduce costs. Bacteria often have to be grown for days and sometimes weeks before they start to make effective amounts of an antibiotic. Sherwood and Bibb were able to trigger production essentially from the beginning of growth.

    The work was funded through JIC’s core strategic grant from BBSRC. Read the study at PNAS: Antibiotic planosporicin coordinates its own production in the actinomycete Planomonospora alba.

    Source: John Innes Centre

    Image: The antibiotic planosporicin is produced by the soil bacterium Planomonospora alba. Credit: John Innes Centre.

    Antimicrobials MRSA
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleFunding Notice: Ecology and Evolution of Infectious Diseases
    Next Article DARPA BAA – Living Foundries 1000 Molecules Program

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy